Research

The study found that chronically disrupted sleep and highly variable sleep durations night after night may increase the risk for atherosclerosis.
February 15, 2023

Study finds chronically disrupted sleep may increase risk for heart disease

Vanderbilt research found that sleep irregularity — chronically disrupted sleep and highly variable sleep durations night after night — may increase the risk for atherosclerosis.

By Bill Snyder
From left, Paula Donahue, PT, DPT, MBA, Aaron Aday, MD, MSc, and Rachelle Crescenzi, PhD, are part of a multidisciplinary effort at VUMC to improve the diagnosis and treatment of lipedema.
February 9, 2023

Team’s imaging strategy enhances lipedema treatment

A collaborative team at Vanderbilt is transforming the diagnosis and treatment of lipedema, a debilitating, abnormal deposition of fatty tissue that afflicts an estimated 17 million women in the United States.

By Bill Snyder
A study found that aspirin counteracts clotting as effectively as other treatments and is also cheaper.
February 9, 2023

Aspirin’s effectiveness at preventing blood clots studied

A Vanderbilt study found that aspirin is as effective as low molecular weight heparin at preventing hospital-acquired deep venous thromboembolism, or blood clots in the veins, for orthopaedic trauma patients.

By Danny Bonvissuto
February 7, 2023

A new view of a cholesterol carrier

Vanderbilt researchers developed a novel method to measure small RNAs carried by HDL and demonstrated that these molecules circulate in greater concentrations than previously believed and are likely to contribute to communication between immune cells.

By Kelsey Pinckard 
(iStock)
February 6, 2023

VUMC’s ‘Shed-MEDS’ protocol can reduce risk of drug interactions in older people

Vanderbilt University Medical Center’s ‘Shed-MEDS’ protocol may reduce risk drug-drug interactions in older peole.

By Bill Snyder
February 6, 2023

Gut microbiota and lung fibrosis

Microorganisms residing in the gut influence the severity of lung fibrosis in mouse models, suggesting that modifying the gut microbiota may offer therapeutic benefit for patients.

By Leigh MacMillan
February 2, 2023

COVID-19 battle begins in the nose

A high upper airway concentration of the virus that causes COVID-19 was associated with changes in gene expression that could impact disease progression, Vanderbilt researchers discovered.
By Sarah E. Glass
February 2, 2023

Researchers clarify role of blood cell mutations in disease

Vanderbilt researchers have developed a new method to analyze mutations in blood stem cells that can trigger explosive, clonal expansions of abnormal cells.
By Bill Snyder
February 2, 2023

Study of two sepsis interventions finds identical outcomes

Vanderbilt University Medical Center had a leading role in a large national study designed to compare two early interventions in the treatment of patients with sepsis, the body’s severe response to an uncontrolled infection.
By Nancy Humphrey
February 2, 2023

Discovery of “cross-reactive” antibodies could aid treatment of viral co-infections

By Bill Snyder
February 2, 2023

Nutrient absorption disease model

Vanderbilt researchers developed a model of a patient-specific mutation to explore the pathology of microvillus inclusion disease, a genetic disorder that causes life-threatening diarrhea.
By Leigh MacMillan
February 2, 2023

Machine learning aids injury prevention in cardiac cath labs

By Paul Govern
January 26, 2023

Nobel laureate Nurse set for year’s first Discovery Lecture

Nobel Prize-winning geneticist and cell biologist Sir Paul Nurse, PhD, will be at Vanderbilt Thursday, Feb. 9, to deliver the year's first Discovery Lecture.
By Bill Snyder
1 … 28 29 30 31 32 … 126